HOME > BUSINESS
BUSINESS
- Japan Ethical Drug Sales Up 0.2% in June: Crecon
August 8, 2019
- Novartis’ Entresto Filed in Japan for Chronic Heart Failure
August 7, 2019
- Keytruda Top-Selling Drug in Japan in April-June: IQVIA
August 7, 2019
- PIII Gets Underway for Astellas’ Hot Flash Drug Fezolinetant
August 7, 2019
- Mitsubishi Tanabe, Jichi Medical Univ. to Commence AMED-Funded Hemophilia Gene Therapy Research
August 7, 2019
- Rohto President “Frustrated” with Slow Pace of Rx-to-OTC Switches in Japan
August 7, 2019
- Suzuken, SanBio Join Forces for Commercial Distribution of Stem Cell Therapy
August 7, 2019
- Keytruda Keeps Top Spot in Drug Sales Ranking in July: Encise
August 7, 2019
- Gearing Up for Japan Debut, Daiichi Sankyo Mounting Push for AML Med Vanflyta
August 6, 2019
- Daiichi Sankyo’s Pexidartinib Bags 1st FDA Nod for Rare Joint Tumor
August 6, 2019
- Fujifilm Completes Buyout of Biogen Manufacturing Unit, Tripling Its Bioreactor Capacity
August 6, 2019
- Ferring to Copromote Regenerative Medicine Product for Fertility Care Facilities
August 6, 2019
- Sosei, Takeda Seal Multi-Target Collaboration Deal
August 6, 2019
- AstraZeneca’s Japan Sales Surge 28% in H1 on Oncology Growth
August 6, 2019
- Rakuten Ups Its Stake in Rakuten Medical to 22.6%
August 5, 2019
- Gene Panel Testing Should Be Done “at an Early Stage”: Chugai Official
August 5, 2019
- Daiichi Sankyo Upping Pitches for Tarlige in May: Impact Track Survey
August 2, 2019
- Kyowa Kirin Buys Back Tivozanib Non-Oncology Rights from AVEO
August 2, 2019
- Kyowa Kirin Nets Double-Digit Growth in 1st Half, Keeps Full-Year Guidance for Nesp
August 2, 2019
- Ono’s Drug Sales Skid in Q1, but Opdivo Royalties Underpin Earnings
August 2, 2019
ページ
Tariffs have been a defining feature of US trade policy under President Donald Trump’s second administration. Since Trump unveiled his “reciprocal” tariff policy in April 2025, the landscape has shifted repeatedly.In February 2026, the US Supreme Court invalidated tariffs imposed…
